Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ESC 23: The ONCO DVT Study
Author(s): Yugo Yamashita Added: 2 years ago
ESC 23 — In this concise interview, Dr Yugo Yamashita (Kyoto University Graduate School of Medicine, JP) reveals the findings of the ONCO DVT Study (NCT03895502). The ONCO DVT study (Takeshi Morimoto) aimed to determine the ideal duration of anticoagulation therapy with the direct oral anticoagulant (DOAC) edoxaban for the treatment of isolated distal deep vein thrombosis (IDDVT) in patients… View more

Anticoagulation

Vascular Disease and Surgery
Systematic Scoping on DOACS in NVAF Patients
Author(s): Shirley Siang Ning Tan , Wei Hong Lai , Lee Len Tiong , et al Added: 3 months ago

Anticoagulation

Electrophysiology & Arrhythmia
AHA 23: KABUKI: DOAC in Pts with CTEPH
Author(s): Kazuya Hosokawa , Abe Kotaro Added: 2 years ago
AHA 2023 — Dr Kazuya Hosokawa and Dr Abe Kotaro (Kyushu University Hospital, JP) join us to share the findings of the KABUKI trial (NCT04730037). The aim of KABUKI (Daiichi Sankyo) is to assess whether edoxaban, a direct factor Xa inhibitor, is noninferior to warfarin in preventing worsening of chronic thromboembolic pulmonary hypertension (CTEPH).This investigator-initiated, multicenter, phase 3… View more

Prevention & Chronic Conditions
Author(s): Apisara Lohachatinante , Nuttanun Kittikunkanyakit , Sayamon Sukkha , et al Added: 1 year ago

Anticoagulation
Anticoagulant Use in Older Adults
Author(s): Monika Bhandari , Akshyaya Pradhan , Pravesh Vishwakarma , et al Added: 9 months ago

Anticoagulation

Electrophysiology & Arrhythmia
Comparative Analysis of Direct Oral Anticoagulants in Atrial Fibrillation
Author(s): Ton Duy Mai , Tri Huynh Quang Ho , Sy Van Hoang , et al Added: 7 months ago

Anticoagulation

Electrophysiology & Arrhythmia
Author(s): Mario DiazNuila-Alcazar , Daniel Valcárcel-Paz , Pablo Del Castillo-Vásquez , et al Added: 1 year ago

Anticoagulation

Electrophysiology & Arrhythmia
ESC 25: Day 4 Wrap-Up with Dr Alasnag and Dr Al-Shaibi
Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 3 months ago
ESC Congress 2025 – The fourth and final day of ESC Congress 2025 maintained momentum with transformative clinical data that will influence cardiovascular practice worldwide.Leading interventional experts Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) offer their expert commentary on the standout hot line trials and their clinical significance from day four.Day 4… View more

Anticoagulation

Electrophysiology & Arrhythmia
Factor XIa Inhibitors’ Future Position in AF
Author(s): Maki Komiyama , Moritake Iguchi , Hiromichi Wada , et al Added: 1 year ago

Anticoagulation
ESC 25: The HI-PRO Trial
Author(s): Gregory Piazza Added: 3 months ago
ESC Congress 2025 - HI-PRO shows apixaban 2.5mg twice daily reduced the risk of symptomatic recurrent venous thromboembolism when compared to placebo at 12 months.Dr Gregory Piazza (Brigham and Women's Hospital, US) joins us to discuss findings from the HI-PRO trial, evaluating extended-duration low-intensity apixaban versus placebo for secondary prevention in high-risk patients with provoked… View more

Anticoagulation

Vascular Disease and Surgery